Global Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Research Report 2023

Publication ID:

PB504233738

Publication Date:

April 21, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Single-photon emission computed tomography (CT) is a radioisotope CT scan and belongs to the category of nuclear medicine.听The imaging principle is a combination of radionuclide development and CT three-dimensional imaging technology, which can show the distribution of radioisotopes in different layers.听SPECT detects ordinary gamma rays, using a radioactive isotope that emits single photons, the radionuclides produced by atomic reactors that emit single photons during decay.
Highlights
The global Single-photon Emission Computed Tomography (SPECT) Systems market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Single-photon Emission Computed Tomography (SPECT) Systems is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Single-photon Emission Computed Tomography (SPECT) Systems is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Single-photon Emission Computed Tomography (SPECT) Systems in Diagnostic Laboratories is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Single-photon Emission Computed Tomography (SPECT) Systems include GE Healthcare, Guerbet, Lantheus Medical Imaging, Daiichi Sankyo, Eli Lillyand Company, Bayer, Gamma Medica-Ideas Inc, Siemens Healthineers and Philips Healthcare, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Single-photon Emission Computed Tomography (SPECT) Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single-photon Emission Computed Tomography (SPECT) Systems.
The Single-photon Emission Computed Tomography (SPECT) Systems market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Single-photon Emission Computed Tomography (SPECT) Systems market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Single-photon Emission Computed Tomography (SPECT) Systems companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
GE Healthcare
Guerbet
Lantheus Medical Imaging
Daiichi Sankyo
Eli Lillyand Company
Bayer
Gamma Medica-Ideas Inc
Siemens Healthineers
Philips Healthcare
Toshiba Medical Systems Corporation
Neusoft Medical Systems
Segment by Type
Hybrid SPECT System
Standalone SPECT System
Segment by Application
Diagnostic Laboratories
Research Institutes
Hospitals
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Single-photon Emission Computed Tomography (SPECT) Systems companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Hybrid SPECT System
1.2.3 Standalone SPECT System
1.3 麻豆原创 by Application
1.3.1 Global Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Diagnostic Laboratories
1.3.3 Research Institutes
1.3.4 Hospitals
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Perspective (2018-2029)
2.2 Single-photon Emission Computed Tomography (SPECT) Systems Growth Trends by Region
2.2.1 Global Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Single-photon Emission Computed Tomography (SPECT) Systems Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Single-photon Emission Computed Tomography (SPECT) Systems Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Dynamics
2.3.1 Single-photon Emission Computed Tomography (SPECT) Systems Industry Trends
2.3.2 Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Drivers
2.3.3 Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Challenges
2.3.4 Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Single-photon Emission Computed Tomography (SPECT) Systems Players by Revenue
3.1.1 Global Top Single-photon Emission Computed Tomography (SPECT) Systems Players by Revenue (2018-2023)
3.1.2 Global Single-photon Emission Computed Tomography (SPECT) Systems Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Single-photon Emission Computed Tomography (SPECT) Systems Revenue
3.4 Global Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Concentration Ratio
3.4.1 Global Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Single-photon Emission Computed Tomography (SPECT) Systems Revenue in 2022
3.5 Single-photon Emission Computed Tomography (SPECT) Systems Key Players Head office and Area Served
3.6 Key Players Single-photon Emission Computed Tomography (SPECT) Systems Product Solution and Service
3.7 Date of Enter into Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Single-photon Emission Computed Tomography (SPECT) Systems Breakdown Data by Type
4.1 Global Single-photon Emission Computed Tomography (SPECT) Systems Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Single-photon Emission Computed Tomography (SPECT) Systems Forecasted 麻豆原创 Size by Type (2024-2029)
5 Single-photon Emission Computed Tomography (SPECT) Systems Breakdown Data by Application
5.1 Global Single-photon Emission Computed Tomography (SPECT) Systems Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Single-photon Emission Computed Tomography (SPECT) Systems Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Size (2018-2029)
6.2 North America Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Size by Country (2018-2023)
6.4 North America Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Size (2018-2029)
7.2 Europe Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Size by Country (2018-2023)
7.4 Europe Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Size (2018-2029)
9.2 Latin America Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Single-photon Emission Computed Tomography (SPECT) Systems 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Detail
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare Single-photon Emission Computed Tomography (SPECT) Systems Introduction
11.1.4 GE Healthcare Revenue in Single-photon Emission Computed Tomography (SPECT) Systems Business (2018-2023)
11.1.5 GE Healthcare Recent Development
11.2 Guerbet
11.2.1 Guerbet Company Detail
11.2.2 Guerbet Business Overview
11.2.3 Guerbet Single-photon Emission Computed Tomography (SPECT) Systems Introduction
11.2.4 Guerbet Revenue in Single-photon Emission Computed Tomography (SPECT) Systems Business (2018-2023)
11.2.5 Guerbet Recent Development
11.3 Lantheus Medical Imaging
11.3.1 Lantheus Medical Imaging Company Detail
11.3.2 Lantheus Medical Imaging Business Overview
11.3.3 Lantheus Medical Imaging Single-photon Emission Computed Tomography (SPECT) Systems Introduction
11.3.4 Lantheus Medical Imaging Revenue in Single-photon Emission Computed Tomography (SPECT) Systems Business (2018-2023)
11.3.5 Lantheus Medical Imaging Recent Development
11.4 Daiichi Sankyo
11.4.1 Daiichi Sankyo Company Detail
11.4.2 Daiichi Sankyo Business Overview
11.4.3 Daiichi Sankyo Single-photon Emission Computed Tomography (SPECT) Systems Introduction
11.4.4 Daiichi Sankyo Revenue in Single-photon Emission Computed Tomography (SPECT) Systems Business (2018-2023)
11.4.5 Daiichi Sankyo Recent Development
11.5 Eli Lillyand Company
11.5.1 Eli Lillyand Company Company Detail
11.5.2 Eli Lillyand Company Business Overview
11.5.3 Eli Lillyand Company Single-photon Emission Computed Tomography (SPECT) Systems Introduction
11.5.4 Eli Lillyand Company Revenue in Single-photon Emission Computed Tomography (SPECT) Systems Business (2018-2023)
11.5.5 Eli Lillyand Company Recent Development
11.6 Bayer
11.6.1 Bayer Company Detail
11.6.2 Bayer Business Overview
11.6.3 Bayer Single-photon Emission Computed Tomography (SPECT) Systems Introduction
11.6.4 Bayer Revenue in Single-photon Emission Computed Tomography (SPECT) Systems Business (2018-2023)
11.6.5 Bayer Recent Development
11.7 Gamma Medica-Ideas Inc
11.7.1 Gamma Medica-Ideas Inc Company Detail
11.7.2 Gamma Medica-Ideas Inc Business Overview
11.7.3 Gamma Medica-Ideas Inc Single-photon Emission Computed Tomography (SPECT) Systems Introduction
11.7.4 Gamma Medica-Ideas Inc Revenue in Single-photon Emission Computed Tomography (SPECT) Systems Business (2018-2023)
11.7.5 Gamma Medica-Ideas Inc Recent Development
11.8 Siemens Healthineers
11.8.1 Siemens Healthineers Company Detail
11.8.2 Siemens Healthineers Business Overview
11.8.3 Siemens Healthineers Single-photon Emission Computed Tomography (SPECT) Systems Introduction
11.8.4 Siemens Healthineers Revenue in Single-photon Emission Computed Tomography (SPECT) Systems Business (2018-2023)
11.8.5 Siemens Healthineers Recent Development
11.9 Philips Healthcare
11.9.1 Philips Healthcare Company Detail
11.9.2 Philips Healthcare Business Overview
11.9.3 Philips Healthcare Single-photon Emission Computed Tomography (SPECT) Systems Introduction
11.9.4 Philips Healthcare Revenue in Single-photon Emission Computed Tomography (SPECT) Systems Business (2018-2023)
11.9.5 Philips Healthcare Recent Development
11.10 Toshiba Medical Systems Corporation
11.10.1 Toshiba Medical Systems Corporation Company Detail
11.10.2 Toshiba Medical Systems Corporation Business Overview
11.10.3 Toshiba Medical Systems Corporation Single-photon Emission Computed Tomography (SPECT) Systems Introduction
11.10.4 Toshiba Medical Systems Corporation Revenue in Single-photon Emission Computed Tomography (SPECT) Systems Business (2018-2023)
11.10.5 Toshiba Medical Systems Corporation Recent Development
11.11 Neusoft Medical Systems
11.11.1 Neusoft Medical Systems Company Detail
11.11.2 Neusoft Medical Systems Business Overview
11.11.3 Neusoft Medical Systems Single-photon Emission Computed Tomography (SPECT) Systems Introduction
11.11.4 Neusoft Medical Systems Revenue in Single-photon Emission Computed Tomography (SPECT) Systems Business (2018-2023)
11.11.5 Neusoft Medical Systems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

GE Healthcare
Guerbet
Lantheus Medical Imaging
Daiichi Sankyo
Eli Lillyand Company
Bayer
Gamma Medica-Ideas Inc
Siemens Healthineers
Philips Healthcare
Toshiba Medical Systems Corporation
Neusoft Medical Systems

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.